UBS Group
MLEC icon

UBS Group’s Moolec Science MLEC Stock Holding History

UBS Group’s Portfolio MLEC Stock Details MLEC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51K Buy
470
+468
+23,400% +$3.76K ﹤0.01% 9178
2026
Q1 		$12 Buy
+2
New +$16 ﹤0.01% 10320
2025
Q4 		– Sell
-700
Closed -$10.3K – 10929
2025
Q3 		$10.3K Buy
+700
New +$28.2K ﹤0.01% 8548
2025
Q2 		– Sell
-13
Closed -$1.08K – 10623
2025
Q1 		$1.08K Sell
13
-10
-43% -$1.14K ﹤0.01% 9581
2024
Q4 		$2.81K Sell
23
-96
-81% -$12.4K ﹤0.01% 8983
2024
Q3 		$15.7K Buy
119
+51
+75% +$7.12K ﹤0.01% 7501
2024
Q2 		$11.2K Buy
68
+21
+45% +$3.98K ﹤0.01% 7655
2024
Q1 		$9.72K Buy
+47
New +$13K ﹤0.01% 7267
2023
Q4 		– Hold
0
– -$129 – 9678
2023
Q3 		– Hold
0
– – – 8826
2023
Q2 		– Sell
-12
Closed -$7.17K – 9370
2023
Q1 		$7.17K Buy
+12
New +$10.8K ﹤0.01% 7839

Other funds holding MLEC

CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

UBS Group's MLEC Position: Q2 2026 in Review

UBS Group increased its Moolec Science (MLEC) stake by 23,400% in Q2 2026, buying an estimated $3.76K and bringing the position to 470 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #9178.

UBS Group first reported a position in MLEC in Q1 2023 and has held it in 9 quarters since. The position peaked at $15.7K in Q3 2024. 3 funds tracked by Wall St. Rank hold MLEC as of Q2 2026.

  • UBS Group held 470 shares of Moolec Science worth $3.51K as of Q2 2026.
  • UBS Group bought 468 Moolec Science shares in Q2 2026, an estimated $3.76K.
  • Moolec Science made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9178 holding.
  • UBS Group first reported a position in Moolec Science in Q1 2023 and has held it in 9 quarters since.
  • UBS Group's Moolec Science position peaked at $15.7K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Moolec Science as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.